CS logo
small CS logo
Maryland Proton Treatment Center

Baltimore, Maryland, United States
Cancer treatment center in Baltimore, Maryland
850 W Baltimore St, Baltimore, MD 21201

About Maryland Proton Treatment Center


"The Maryland Proton Treatment Center is the first and most experienced proton therapy center in the region. Our center has trained more than 200 medical professionals on the use of proton therapy, including physicians from new and upcoming proton centers in the region."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Maryland Proton Treatment Center


During the past decade, Maryland Proton Treatment Center conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 2 clinical trials were completed, i.e. on average, 11.8% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 2 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Maryland Proton Treatment Center" #1 sponsor was "NRG Oncology" with 7 trials, followed by "Proton Collaborative Group" with 5 trials sponsored, "University of Maryland, Baltimore" with 5 trials sponsored, "Alliance for Clinical Trials in Oncology" with 1 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Maryland Proton Treatment Center" #1 collaborator was "National Cancer Institute (NCI)" with 10 trials as a collaborator, "Keep Punching Foundation" with 1 trials as a collaborator, "NRG Oncology" with 1 trials as a collaborator and "Radiation Therapy Oncology Group" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

Clinical Trials Conditions at Maryland Proton Treatment Center


According to Clinical.Site data, the most researched conditions in "Maryland Proton Treatment Center" are "Prostate Cancer" (3 trials), "Breast Cancer" (2 trials), "Breast Neoplasm" (2 trials), "Breast Tumor" (2 trials) and "Cancer of the Breast" (2 trials). Many other conditions were trialed in "Maryland Proton Treatment Center" in a lesser frequency.

Clinical Trials Intervention Types at Maryland Proton Treatment Center


Most popular intervention types in "Maryland Proton Treatment Center" are "Radiation" (19 trials), "Drug" (10 trials), "Other" (8 trials), "Procedure" (4 trials) and "Biological" (3 trials). Other intervention types were less common.
The name of intervention was led by "Cisplatin" (4 trials), "Proton Beam Radiation Therapy" (4 trials), "Carboplatin" (3 trials), "Quality-of-Life Assessment" (3 trials) and "Questionnaire Administration" (3 trials). Other intervention names were less common.

Clinical Trials Genders at Maryland Proton Treatment Center


The vast majority of trials in "Maryland Proton Treatment Center" are 18 trials for "All" genders, 3 trials for "Male" genders and 2 trials for "Female" genders.

Clinical Trials Status at Maryland Proton Treatment Center


Currently, there are NaN active trials in "Maryland Proton Treatment Center". undefined are not yet recruiting, 17 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Maryland Proton Treatment Center, undefined suspended trials, and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Maryland Proton Treatment Center, 2 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".